🇺🇸 PF-04360365 in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 10

Most-reported reactions

1. Agitation — 1 report (10%)
2. Anaemia — 1 report (10%)
3. Constipation — 1 report (10%)
4. Convulsion — 1 report (10%)
5. Delirium — 1 report (10%)
6. Fatigue — 1 report (10%)
7. Gait Disturbance — 1 report (10%)
8. Haemoglobin Decreased — 1 report (10%)
9. Hypotension — 1 report (10%)
10. Syncope — 1 report (10%)

Source database →

Frequently asked questions

Is PF-04360365 approved in United States?

PF-04360365 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for PF-04360365 in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.